Virginia judge orders FDA to revisit Biden-era mifepristone restrictions

A federal judge in Virginia has ruled that the FDA must reexamine certain restrictions on the abortion medication mifepristone that were put in place during the previous administration.

The judge concluded that the earlier rules were overly burdensome and exceeded the agency's authority, directing the FDA to conduct a new review of the policy.

The decision comes as the federal government continues to assess the regulatory framework for medication abortion, potentially affecting access to the drug nationwide.